Published on in Vol 25 (2023)
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/41867, first published
.
![Communicating Health Literacy on Prescription Medications on Social Media: In-depth Interviews With “Patient Influencers” Communicating Health Literacy on Prescription Medications on Social Media: In-depth Interviews With “Patient Influencers”](https://asset.jmir.pub/assets/53c34a6c7f95d2a9744e3da69cfe9976.png 480w,https://asset.jmir.pub/assets/53c34a6c7f95d2a9744e3da69cfe9976.png 960w,https://asset.jmir.pub/assets/53c34a6c7f95d2a9744e3da69cfe9976.png 1920w,https://asset.jmir.pub/assets/53c34a6c7f95d2a9744e3da69cfe9976.png 2500w)
Journals
- Looi M. Sixty seconds on . . . patient influencers. BMJ 2023:p705 View
- Engel E, Gell S, Heiss R, Karsay K. Social media influencers and adolescents’ health: A scoping review of the research field. Social Science & Medicine 2024;340:116387 View
- Katona N, Szabó R, Szeberényi A. Determining Marketing and Communication Dimensions of Healthcare Providers in Hungary. Visegrad Journal on Bioeconomy and Sustainable Development 2023;12(2):45 View
- Albeshry A, Alshahrani N, Baklola M, Terra M. From Style to Wellness: How Fashion Influencers Are Affecting Healthy Behaviors in Saudi Arabia. Cureus 2024 View
- Astărăstoae V, Rogozea L, Leaşu F, Roşca S. Drug Promotions Between Ethics, Regulations, and Financial Interests. American Journal of Therapeutics 2024;31(3):e268 View
- Lees E. Irritable Bowel Syndrome (IBS) and medical misinformation: lessons to be learned from the COVID-19 infodemic. Journal of Evidence-Based Healthcare 2024;6:e5444 View